![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/spacer.gif)
A-007 The phenylhydrazone 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone formulated as a topical agent with immunomodulating and potential antineoplastic activities. Applied topically as a 0.25% gel, A-007 may stimulate a local immune response against human papillomavirus (HPV)-induced cervical intraepithelial neoplasia (CIN). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/spacer.gif)
Chemical structure name: | ![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/spacer.gif) | 4,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone | | ![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/eot2008/20081024141830im_/http://www.cancer.gov/images/spacer.gif) |